Literature DB >> 8859915

Diagnosis of whooping cough: a new era with rapid molecular diagnostics.

N Cimolai1, C Trombley, D O'Neill.   

Abstract

A rapid diagnostic procedure, which is based upon the polymerase chain reaction (PCR) genetic amplification technology, was utilized to establish the presence of Bordetella pertussis in nasopharyngeal washes from children. Overall, 14.7% of 456 specimens were positive by either culture or the rapid assay. Culture and PCR were concordant for 62.7% of positive samples; PCR provided an additional increment of 37.3%. PCR-positive, culture-negative specimens were more likely to be found among older patients with more prolonged illness and previous erythromycin therapy (P < 0.01 for all three comparisons). As a single laboratory assay, PCR should be recognized as the current standard for diagnosis.

Entities:  

Mesh:

Year:  1996        PMID: 8859915     DOI: 10.1097/00006565-199604000-00006

Source DB:  PubMed          Journal:  Pediatr Emerg Care        ISSN: 0749-5161            Impact factor:   1.454


  4 in total

1.  Abundance of the nasopharyngeal microbiome effects pertussis diagnosis and explains the sensitivity difference between bacterial culture and real-time PCR.

Authors:  Yijun Ding; Qing Wang; Dongfang Li; Kaihu Yao; Tianyou Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-03       Impact factor: 3.267

2.  Comparison of PCR, culture, and direct fluorescent-antibody testing for detection of Bordetella pertussis.

Authors:  M J Loeffelholz; C J Thompson; K S Long; M J Gilchrist
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

3.  Comparison of culture and real-time PCR for detection of Bordetella pertussis isolated from patients in Iran.

Authors:  Vajiheh Sadat Nikbin; Fereshteh Shahcheraghi; Masoumeh Nakhost Lotfi; Seyyed Mohsen Zahraei; Masoumeh Parzadeh
Journal:  Iran J Microbiol       Date:  2013-09

Review 4.  Non-primate animal models for pertussis: back to the drawing board?

Authors:  Nevio Cimolai
Journal:  Appl Microbiol Biotechnol       Date:  2022-02-01       Impact factor: 4.813

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.